Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

18.6K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.6K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.3K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Trajectories of Brain Health Risk Factors Measured by the Brain Care Score and Risk of Stroke, Dementia, and Depression.

Annals of neurology·2026
Same author

Association of Plasma GFAP and NfL in Middle-Aged Adults With MRI Markers of Cerebral Small Vessel Disease Later in Life.

Neurology·2025
Same author

Association of Modifiable Risk Factors Measured With the Brain Care Score and Incident Stroke in the REGARDS Cohort.

Neurology·2025
Same author

Enhancing Comorbidity Management in Patients With Hemorrhagic Stroke via an Electronic Health Record-Linked Best Practice Alert: A Pre/Post Study.

Journal of the American Heart Association·2025
Same author

Association of Leucocyte Telomere Length With Stroke, Dementia, and Late-Life Depression: The Role of Modifiable Risk Factors.

Neurology·2025
Same author

A multi-omics resource of B cell activation reveals genetic mechanisms for immune-mediated diseases.

medRxiv : the preprint server for health sciences·2025

Related Experiment Video

Updated: Jan 13, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

12.2K

Copy Number Variants and Their Association With Intracerebral Hemorrhage Risk: A Case-Control Study.

Savvina Prapiadou1,2,3, Carl D Langefeld4,5, Padmini Sekar6

  • 1Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Annals of Clinical and Translational Neurology
|October 29, 2025
PubMed
Summary

This study investigated copy number variants (CNVs) in Intracerebral Hemorrhage (ICH) but found no significant genetic associations. Future research should explore potential links to cholesterol biosynthesis and blood vessel development in ICH.

Keywords:
copy number variantsgeneticsintracerebral hemorrhage

More Related Videos

Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model
08:18

Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model

Published on: February 8, 2022

2.9K
Detection of Copy Number Alterations Using Single Cell Sequencing
09:45

Detection of Copy Number Alterations Using Single Cell Sequencing

Published on: February 17, 2017

12.1K

Related Experiment Videos

Last Updated: Jan 13, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

12.2K
Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model
08:18

Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model

Published on: February 8, 2022

2.9K
Detection of Copy Number Alterations Using Single Cell Sequencing
09:45

Detection of Copy Number Alterations Using Single Cell Sequencing

Published on: February 17, 2017

12.1K

Area of Science:

  • Genetics
  • Neurology
  • Genomics

Background:

  • Intracerebral Hemorrhage (ICH) is a major global health issue with limited treatments.
  • The genetic factors contributing to ICH remain largely unknown.
  • Copy Number Variants (CNVs) are potential contributors to ICH pathophysiology.

Purpose of the Study:

  • To investigate the role of CNVs in the risk of ICH.
  • To identify novel etiological mechanisms and therapeutic targets for ICH.
  • To explore associations between large, rare CNVs and ICH risk.

Main Methods:

  • Analysis of microarray data from 649 ICH cases and 437 controls.
  • Utilized PennCNV software for CNV detection and rigorous quality control.
  • Performed functional enrichment analysis to identify relevant biological pathways.

Main Results:

  • Genic CNVs were more frequent in ICH cases (39.6%) than controls (32.5%), p=0.02.
  • CNVs related to cholesterol biosynthesis (6.3% vs. 3.2%, p=0.04) and blood vessel development (8.2% vs. 5.3%, p=0.06) showed trends in cases.
  • No significant associations withstood correction for multiple comparisons.

Conclusions:

  • This is the first study to analyze CNVs in relation to ICH risk.
  • No definitive link was established between large, rare CNVs and ICH.
  • Identified trends suggest potential avenues for future research into CNVs and ICH pathogenesis.